Cargando…
US FDA Drug Approvals are Persistent and Polycyclic: Insights into Economic Cycles, Innovation Dynamics, and National Policy
It is challenging to elucidate the effects of changes in external influences (such as economic or policy) on the rate of US drug approvals. Here, a novel approach—termed the Chronological Hurst Exponent (CHE)—is proposed, which hypothesizes that changes in the long-range memory latent within the dyn...
Autor principal: | Daizadeh, Iraj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009272/ https://www.ncbi.nlm.nih.gov/pubmed/33786755 http://dx.doi.org/10.1007/s43441-021-00279-8 |
Ejemplares similares
-
RETRACTED ARTICLE: Seasonal and Secular Periodicities Identified in the Dynamics of US FDA Medical Devices (1976–2020): Portends Intrinsic Industrial Transformation and Independence of Certain Crises
por: Daizadeh, Iraj
Publicado: (2021) -
The Impact of US Medical Product Regulatory Complexity on Innovation: Preliminary Evidence of Interdependence, Early Acceleration, and Subsequent Inversion
por: Daizadeh, Iraj
Publicado: (2023) -
Since the Mid-2010s FDA Drug and Biologic Guidelines have been Growing at a Faster Clip than Prior Years: Is it Time to Analyze Their Effectiveness?
por: Daizadeh, Iraj
Publicado: (2020) -
Has the COVID-19 Crisis Affected the Growth of United States Food and Drug Administration Drug Approvals? The Answer is Not Yet! A Time Series (Forecasting) Study
por: Daizadeh, Iraj
Publicado: (2020) -
Pharmacogenomic Biomarkers in US FDA-Approved Drug Labels (2000–2020)
por: Kim, Jeeyun A., et al.
Publicado: (2021)